Research news, analysis and insights

Cross-Reactive Bactericidal Antimeningococcal Antibodies

The threat from invasive meningococcal disease (IMD) remains a serious source of concern despite the licensure and availability of vaccines. A limitation of current serogroup B vaccines is the breadth of coverage afforded, resulting from the capacity for extensive variation of the meningococcus and its huge potential for the generation of further diversity.

Publication

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Article

Teaching university subjects online, changing technology and pedagogical practice

Next Article

A Different Kind of Teacher for a Different Kind of School

×
You have free insight(s) remaining for this month.
Related Posts
error: Faculti Content is protected. Please check our Privacy Policy and Terms and Conditions.

Add the Faculti Web App to your Mobile or Desktop homescreen

Install
×